| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.085 | 0.04 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |